|
RNPC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.137800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.083600E-01 |
| Normal-vs-Stage2 |
3.682200E-01 |
| Normal-vs-Stage3 |
9.642300E-03 |
| Normal-vs-Stage4 |
9.785600E-01 |
| Stage1-vs-Stage2 |
5.237000E-01 |
| Stage1-vs-Stage3 |
1.583690E-04 |
| Stage1-vs-Stage4 |
8.618400E-01 |
| Stage2-vs-Stage3 |
4.432500E-02 |
| Stage2-vs-Stage4 |
5.934800E-01 |
| Stage3-vs-Stage4 |
4.066800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.048200E-01 |
| Normal-vs-AfricanAmerican |
4.383200E-01 |
| Normal-vs-Asian |
3.122200E-01 |
| Caucasian-vs-AfricanAmerican |
9.682600E-01 |
| Caucasian-vs-Asian |
3.333200E-01 |
| AfricanAmerican-vs-Asian |
1.039010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.355400E-01 |
| Normal-vs-Female |
2.426400E-01 |
| Male-vs-Female |
4.620400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.830200E-01 |
| Normal-vs-Extreme_Weight |
5.022800E-01 |
| Normal-vs-Obese |
5.653400E-01 |
| Normal-vs-Extreme_Obese |
4.608400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.737800E-01 |
| Normal_Weight-vs-Obese |
8.263800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.133000E-01 |
| Extreme_Weight-vs-Obese |
9.341800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.196600E-01 |
| Obese-vs-Extreme_Obese |
5.628000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.633600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.561600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.264600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.349600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.073770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.283200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.514200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.797900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.540100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.621400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.347900E-02 |
| Normal-VS-Type2 PRCC |
3.029800E-02 |
| Normal-VS-KIRP CIMP |
3.243500E-02 |
| Normal-VS-Unclassified PRCC |
3.603000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.04569999992421E-07 |
| Type1 PRCC-VS-KIRP CIMP |
8.44010000000672E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.315200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.859800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.158270E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.278000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.125610E-01 |
| Normal-vs-N1 |
5.809400E-01 |
| Normal-vs-N2 |
2.284000E-01 |
| N0-vs-N1 |
7.079800E-01 |
| N0-vs-N2 |
5.003400E-01 |
| N1-vs-N2 |
5.971600E-01 |
|
|
